|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Medicine, Division of Physiology, and
Department of Biology, University of Fribourg, Fribourg, Switzerland;
Centre for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia; and
Department of Basic Neurosciences, Faculty of Medicine, University of Geneva, Geneva, Switzerland
1Correspondence: Department of Medicine, Division of Physiology, University of Fribourg, Rue du Musée 5, CH-1700 Fribourg, Switzerland. E-mail: abdul.dulloo{at}unifr.ch
| ABSTRACT |
|---|
|
|
|---|
Key Words: thermogenesis weight cycling catch-up growth obesity diabetes
| INTRODUCTION |
|---|
|
|
|---|
The molecular mechanisms underlying this adipose-specific control of thermogenesis are unknown. However, the demonstration that the preferential catch-up fat caused by suppressed thermogenesis persists unabated under both conditions of cold exposure (when sympathetically mediated thermogenesis is markedly elevated) and at thermoneutrality (when sympathetically mediated thermogenesis is minimal) (14)
has indicated that this thrifty metabolism favoring catch-up fat can be dissociated from diminished sympathetic neural control of thermogenesis and, by extension, from sympathetic modulation of the uncoupling protein (UCP) 1 in brown adipose tissue. Subsequent interest in the possibility that such regulated thermogenesis in skeletal muscle may involve altered mitochondrial uncoupling by UCP2 or UCP3 (members of the UCP family) has waned after the demonstration that they are either up-regulated during fasting (15
16
17
18)
or unaltered in response to semistarvation and refeeding (19)
. Indeed, a role for UCP2 and UCP3 in the control of thermogenesis and energy balance is still being debated (18
19
20
21)
.
There is now renewed interest in the potential role of futile (energy-dissipating) cycles in understanding the biochemical basis of skeletal muscle thermogenesis. In this context, mice with genetic ablation of stearoyl-CoA desaturase 1 (SCD1), a rate-limiting enzyme that catalyzes fatty acid desaturation at the
9 position, display a hypermetabolic phenotype (22
, 23)
, which was proposed to be mediated by a futile cycle between de novo lipogenesis and lipid oxidation (24)
. Furthermore, the findings that after caloric restriction, rats refed with a chow diet showed elevations in SCD1 gene expression and in indices of SCD1-related fatty acid
9 desaturation in skeletal muscle raised the possibility for a role of increased muscle SCD1 activity in the suppressed thermogenesis driving catch-up fat (24)
. As the latter study was in progress, it was reported that the hypermetabolic SCD1-knockout mice display increased activation of insulin receptor substrate (IRS) 1-associated phosphatidylinositol-3-kinase (PI3K) as well as AMP-activated protein kinase (AMPK) in skeletal muscle (25
, 26)
. We found these observations to be of particular interest in light of our ex vivo microcalorimetric studies in intact skeletal muscle demonstrating that the direct effects of leptin and corticotropin-releasing hormone in stimulating muscle thermogenesis correlate with AMPK and PI3K signaling and can be blocked by selective inhibitors of either AMPK or PI3K (27
28
29)
. These studies therefore strongly suggest that both PI3K and AMPK signaling are required for hormonal control of thermogenesis in skeletal muscle.
On the basis of these findings, we investigated here whether IRS1-associated PI3K activity or AMPK phosphorylation is impaired in skeletal muscle of rats during catch-up fat and could thus be implicated in the thrifty metabolism of suppressed thermogenesis that drives catch-up fat after caloric restriction. To this end, we have used a previously described rat model of semistarvation-refeeding, in which catch-up fat results solely from suppressed thermogenesis, to assess IRS1-associated PI3K activity and AMPK phosphorylation in two skeletal muscle types, tibialis anterior (a fast-twitch glycolytic muscle) and soleus muscle (a slow-twitch oxidative muscle), which were harvested under the unstimulated (basal) state as well as under in vivo stimulated states after administration of either insulin (an inducer of PI3K) or leptin (an activator of AMPK). These investigations were first carried out during catch-up fat with a chow (low-fat) diet and subsequently were repeated during isocaloric refeeding with a high-fat (typical Western) diet, which is known to further exacerbate the thrifty metabolism that drives catch-up fat (11)
. These studies are interpreted with data from concomitant assays of muscle lipid content, SCD1 gene expression, and SCD1-associated fatty acid
9 desaturation, as well as with data from blood or urinary assays of hormones implicated in the control of muscle thermogenesis (thyroid hormones, leptin, and catecholamines).
| MATERIALS AND METHODS |
|---|
|
|
|---|
Design of study I: catch-up fat with chow diet
In a first set of experiments (study 1), the specific design of which has been reported before (9
10
11)
and is depicted in Fig. 1
A), groups of 7-wk-old rats are food-restricted at 50% of their spontaneous chow intake for 2 wk. After this period of semistarvation, they are refed the same standard chow diet, which is low in fat and high in unrefined carbohydrates (Supplemental Table 1) at a level equal in metabolizable energy content to the spontaneous food intake of control rats matched for weight at the onset of refeeding. The cardinal feature of this experimental design, therefore, is that comparisons are made between refed animals regaining weight vs. spontaneously growing weight-matched controls, with both groups consuming the same amount of food energy. Under these conditions, the refed animals show an increased rate of body fat gain for a period of 2–3 wk, owing to 10–13% lower energy expenditure than controls (9
10
11)
and confirmed here in Fig. 1A
. A number of factors that could theoretically contribute to this difference in energetics between refed and control rats (namely, protein mass, size of organs, age, and level of physical activity) have been evaluated previously and were shown to have little or no impact on the difference in energy expenditure between the two groups (9
, 10)
. The lack of between-group differences in lean body mass is also confirmed here as judged from our data presented in Supplemental Fig. 1A, indicating that the body protein mass is similar in refed and control groups during the course of catch-up fat; hence, no correction is required for adjusting energy expenditure relative to lean body mass for between-group comparison. Consequently, under conditions of our refeeding studies, the lower energy expenditure in refed than in control rats is explained essentially by the energy spared as a result of sustained suppression of thermogenesis for the purpose of catch-up fat. In the study reported here, the experiments were conducted for a period corresponding to 9 days of refeeding, i.e., the time point at which body fat of the refed animals had not yet exceeded that of controls (Fig. 1)
. In two separate experiments here, groups of refed and control animals (n=12–18) were sacrificed after in vivo bolus administration of either insulin or saline (the PI3K experiment) and after in vivo bolus administration of leptin or saline (the AMPK experiment).
|
Design of study II: catch-up fat with high-fat diet
In a second set of experiments comparing semisynthetic diets high or low in dietary fats, the specific design of which is similar to that reported previously (11)
and depicted in Fig. 1B
), groups of spontaneously growing rats, referred to as fed controls, were fed either the low-fat diet (n=12) or an isocaloric amount of the high-fat diet rich in lard (n=12) for a period of 10 days; the compositions of these semisynthetic diets are presented in Supplemental Table 1, and details of measurements of the metabolizable energy content of these diets have been reported previously (11)
. Two additional groups of rats were semistarved for 14 days as described above and during subsequent refeeding lasting 10 days, one group (n=12) was refed with the low-fat diet and the other group (n=12) was refed with isocaloric amounts of the high-fat diet. All groups were thus provided with the same amount of metabolizable energy intake, which corresponds to that consumed during spontaneous food intake of pelletted chow. Under these conditions, the suppression of thermogenesis that favors catch-up fat with the low-fat diet was found to be exacerbated during refeeding with the high-fat diet (11)
, findings that are confirmed here in Fig. 1B
as indicated by a more pronounced effect of the high-fat diet on energy expenditure in refed animals than in fed controls, namely, refed high-fat diet < refed low-fat diet by
12% (P<0.001) compared with control high-fat diet < control low-fat diet by 4% (P<0.05). This exacerbated reduction in absolute energy expenditure is independent of differences in lean body mass, as judged from our data (shown in Supplemental Fig. 1B), indicating that there were no differences in body protein mass in refed (or control) groups fed with the high-fat and low-fat diets. In separate experiments of similar design, subgroups of refed and fed control animals were sacrificed on day 10 after in vivo bolus administration of either saline or insulin (PI3K experiments) and after in vivo bolus administration of saline or leptin (AMPK experiments).
In vivo bolus administration of insulin and leptin
On the last day of each experiment, the rats were fasted from 7:00 AM, and 5–7 h later (i.e., between 12:00 and 2:00 PM), subgroups of rats were anesthetized by injection of ketamine/xylazine (39:5 mg/kg body weight) and surgically prepared for a bolus injection (through the jugular vein) of either insulin (10 U/kg body weight) (Actrapid, Novo Nordisk, Bagsvaerd, Denmark), recombinant leptin (1 mg/kg body weight) (Insight Biotechnology, Wembley, UK), or an equal volume of saline vehicle. In the AMPK experiments, leptin or saline was injected 15 min before sacrifice of animals and tissue harvest, whereas in the PI3K experiments, insulin or saline was injected 3 min before sacrifice and tissue harvest. Immediately after sacrifice, the skeletal muscles (tibialis anterior and soleus) were rapidly dissected, frozen in liquid nitrogen, and stored at –80°C until analysis. The timing for tissue harvesting after hormonal administration and the doses of hormones used correspond to maximal activation of PI3K and AMPK assessed in preliminary studies, consistent with values obtained by others (30
, 31)
.
Protein extraction and Western blotting
Frozen tissues were homogenized under liquid nitrogen and incubated in lysis buffer [20 mM Tris-HCl, 138 mM NaCl, 2.7 mM KCl, 5% (v/v) glycerol, 1% (v/v) Nonidet P-40, and various hydrolase inhibitors] for 15 min. After centrifugation at 15,000 rpm for 15 min, the protein concentration in the supernatant was quantified, and the protein extracts were used for further measurements. For Western blot analysis of phosphorylation of AMPK (Thr-172) and its downstream target acetyl-CoA carboxylase (ACC) (Ser-79, equal amounts of proteins were separated by SDS-PAGE and blotted on polyvinylidene difluoride membranes that were analyzed with polyclonal antibodies (Cell Signaling Technology, Inc., Danvers, MA, USA) raised against the indicated phosphorylation sites. Bands within the linear range were quantified densitometrically. Total protein amounts of AMPK
and ACC were also measured in the same way by using corresponding antibodies.
PI3K activity
Protein extract (200–500 mg) was immunoprecipitated with IRS-1 (Upstate Biotechnology, Lake Placid, NY, USA) polyclonal antibody. The kinase reaction, thin-layer chromatography separation, and signal detection were performed as described previously (28
, 29)
and according to the method of Pirola et al. (32)
.
Intramyocellular lipids and SCD1-related fatty acid
9 desaturation
The content of neutral lipids in skeletal muscle myocytes was determined using an oil red O stain, as described previously (12)
and according to the method of Russell et al. (33)
. An index of SCD1-related fatty acid
9 desaturation was determined using the quantitated values for palmitate (C16:0), palmitoleate (C16:1), stearate (C18:0), and oleate (C18:1) in the phospholipid fraction as well as in the triglyceride fraction of muscle lipids obtained after fractionation by thin-layer chromatography and subsequent analysis of fatty acid methyl esters by gas chromatography/mass spectrometry, as detailed previously (24)
. The
9 desaturation index was calculated as the ratio of product to substrate (C16:1/C16:0 and C18:1/C18:0).
SCD1 expression
The gene expression analysis for SCD1 was performed by real-time polymerase chain reaction, as detailed previously (24)
, using iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA), with the following primers: cyclophilin forward 5' TCA GGG CTC TTG AAG TCC C 3' and reverse 5' CAG AAA ATC ACA GCA GCC AAC 3'; and rat SCD1 forward 5' TGG GAA AGT GAA GCG AGC AAC CG 3' and reverse 5' AGA GGG GCA CCT TCT TCA TCT TCT C 3'.
Plasma hormones and urinary catecholamines
Plasma thyroid hormone (T3) and leptin were measured using RIA kits (Linco Research, St. Charles, MO, USA). Catecholamines were assayed from urine collected during the last 4 days of the refeeding period using liquid chromatography with electrochemical detection, as described previously (24)
.
Body composition
The whole carcasses were dried to a constant weight in an oven maintained at 70°C and subsequently homogenized for analysis of energy content by bomb calorimetry (34)
and for fat content by the Soxhlet extraction method (35)
. Body protein was determined from a general formula relating energy derived from fat, the total energy value of the carcass, and energy derived from protein (9)
.
Data analysis and statistics
All data are presented as means ± SE. For the study comparing refed and control animals in response to hormone or saline, the data were analyzed by two-factor ANOVA for the main effects of groups (refed vs. control), treatment (hormone vs. saline), and group x treatment interactions. For the other study comparing animals consuming the high-fat and low-fat diets in response to hormone or saline, the data were analyzed by two-factor ANOVA for the main effects of diet (high-fat vs. low fat), treatment (hormone vs. saline), and diet x treatment interactions; these analyses were conducted separately under conditions of feeding or refeeding. For both studies, post hoc pairwise comparisons were performed by unpaired t test. The statistical treatment of data was performed using the computer software STATISTIK (version 4.0; Analytical Software, St. Paul, MN, USA).
| RESULTS |
|---|
|
|
|---|
|
AMPK phosphorylation
The data on AMPK signaling in skeletal muscles in response to saline (basal levels) or to in vivo administration of leptin in refed and control groups, presented in Fig. 3
, indicate no between-group differences in the phosphorylation of AMPK. More specifically, in vivo leptin administration did not result in significant increases in AMPK phosphorylation in tibialis anterior muscle from refed or control groups. Although in soleus muscle, the administration of leptin resulted in significant increases in AMPK phosphorylation by 1.6-fold (P<0.01), this response is comparable across the refed and control groups. The data on phosphorylation of ACC (a downstream target of AMPK) were similar to those obtained for AMPK phosphorylation and are presented in Supplemental Fig. 2, i.e., no change in the tibialis anterior muscle in either refed or fed control rats and comparable increases in response to leptin in soleus muscle of refed and fed animals.
|
Study II: catch-up fat with high-fat diet
PI3K activity
The results for the impact of increased fat in the diet on IRS-1-associated PI3K activity in tibialis anterior muscle after feeding and refeeding with the semisynthetic low-fat or high-fat (lard) diets are presented in Fig. 4
, top panel. Between-diet comparisons in the fed controls (control high-fat vs. control low-fat) indicate no differences in basal or insulin-stimulated PI3K activity (Fig. 4
, left-hand panel). In contrast, in the refed groups consuming isocaloric amounts of these two diets for the same time period of 10 days (Fig. 4
, right-hand panel), there was an overall significant effect of diet on PI3K activity in tibialis anterior (refed high-fat diet vs. refed low-fat diet; P<0.05 by ANOVA), with a more pronounced effect of the high-fat diet in lowering basal PI3K activity across saline treatment (–30%, P<0.05) than in lowering insulin-stimulated PI3K activity (–17%, not significant). In contrast to these between-diet differences in the tibialis anterior of refed animals, no differences were observed in basal or insulin-stimulated PI3K activity in soleus muscle from refed groups nor from fed control groups, as shown in Fig. 4
, bottom panel.
|
Intramyocellular lipids and
9 desaturation
After finding that skeletal muscle PI3K activity is lower during high-fat refeeding in only the tibialis anterior, in further studies we examined whether the lower PI3K activity in this muscle could be related to an elevated intramyocellular lipid content or to an up-regulation of SCD1 because both have been implicated in diminished PI3K signaling in skeletal muscle (25
, 26)
and also because of recent findings implicating a role for muscle SCD1 up-regulation in the mechanisms by which thermogenesis might be suppressed during catch-up fat with a low-fat diet (24)
. The data presented in Table 1
, however, indicate that, like plasma free fatty acids (FFAs), the intramyocellular lipid content is not significantly different in muscles of animals consuming the high-fat diet vs. the low-fat diet after 10 days of isocaloric refeeding (refed high-fat diet vs. refed low-fat diet). Furthermore, SCD1 mRNA levels were not higher in response to high-fat vs. low-fat refeeding but, surprisingly, were markedly reduced in the refed animals consuming the high-fat diet (Table 1)
. These lower muscle SCD1 expressions during high-fat refeeding are associated with reductions in the SCD1-related fatty acid
9 desaturation index (assessed as changes in C16:1/C16:0 or in C18:1/C18:0) in both the muscle phospholipid fraction as well as in the muscle triglyceride lipid fraction (Fig. 5
); similar reductions in SCD1 gene expression and the SCD1-related fatty acid
9 desaturation index were also observed in control animals fed with the high-fat diet.
|
|
AMPK phosphorylation
The results of AMPK signaling in skeletal muscle after feeding and refeeding with the low-fat or high-fat diets for 10 days are presented in Fig. 6
for both tibialis anterior and soleus. Comparisons across the fed controls (control high-fat diet vs. control low-fat diet) indicated no between-diet differences in basal or leptin-stimulated AMPK in both tibialis anterior and soleus. In contrast, comparisons across the refed groups (refed high-fat diet vs. refed low-fat diet) indicate an effect of the high-fat diet in lowering AMPK phosphorylation in both tibialis anterior (by 15–20%) and in soleus (by 20–25%), with ANOVA indicating an overall significant difference (P<0.05) across diets and with the reductions in basal AMPK accounting for >50% of the reductions in leptin-stimulated AMPK phosphorylation. Similarly, the phosphorylation of ACC was also found to be lower, specifically in animals refed the high-fat diet than in those fed the low-fat diet in both muscles (Supplemental Fig. 3), with the between-diet differences in ACC phosphorylation, as for AMPK phosphorylation, being observed only in muscles from refed animals but not in those from fed controls.
|
Thermogenic hormones
To test whether our findings of impaired muscle AMPK during refeeding with the high-fat diet might be associated with lower circulating levels of thermogenic hormones that have been implicated in AMPK activation in skeletal muscle, namely leptin (31)
, the thyroid hormone T3 (36)
, and catecholamines (31
, 37)
, we also determined plasma concentrations of leptin and T3, as well as urinary excretion rates of catecholamines for indices of altered sympathetic and adrenal medullary activity. As shown in Table 2
, none of these hormones were found to be lower during high-fat refeeding. On the contrary, plasma leptin concentrations and urinary norepinephrine excretion rates were significantly higher during high-fat refeeding than during low-fat refeeding (refed high-fat diet vs. refed low-fat diet) by 55% (P<0.001) and by 17% (P<0.01), respectively; these effects of the high-fat diet in increasing circulating leptin concentration and urinary norepinephrine excretion rate being observed only in the refed group and not in fed controls (Table 2)
.
|
| DISCUSSION |
|---|
|
|
|---|
Catch-up fat with low-fat diet
A comparison between refed and fed control animals consuming isocaloric amounts of a low-fat (chow) diet indicates no detectable differences in AMPK phosphorylation but consistently lower IRS1-associated PI3K activity in skeletal muscle during early catch-up fat. PI3K activity is significantly lower during refeeding both in the fast-twitch glycolytic muscle (tibialis anterior) and in the slow-twitch oxidative muscle (soleus). Furthermore, lower muscle PI3K activity in refed than in control animals is observed in the unstimulated (basal) state as well as after in vivo insulin administration. Taken together, these data demonstrate that during catch-up fat, skeletal muscle has a reduced pool of IRS1-associated PI3K activity and a defective induction by insulin. These findings, together with our previous studies of ex vivo microcalorimetry implicating a role for PI3K activity and insulin in skeletal muscle thermogenesis (27
28
29)
, suggest that the defective IRS1-associated PI3K activity in both basal and in response to insulin stimulation might be important in the suppressed thermogenesis that favors catch-up fat. Moreover, the lower insulin-stimulated PI3K activity in skeletal muscle during refeeding suggests that a defect in the early steps of insulin signaling might be the molecular defect linking suppressed thermogenesis and insulin resistance during catch-up fat. This hypothesis is supported by studies with a euglycemic-hyperinsulinemic clamp showing that insulin-stimulated glucose utilization in skeletal muscle is lower in refed animals than in controls, a reduction that precedes excess body fat, elevated intramyocellular lipids, or elevated circulating FFAs (11
12)
, thereby suggesting that insulin resistance in skeletal muscle during catch-up fat occurs before overt lipotoxic stress.
Catch-up fat with high-fat diet
Further support of a role for impaired PI3K activity in the suppression of thermogenesis driving catch-up fat can also be derived from our findings in animals refed with a high-fat diet. We have shown previously (11)
and confirmed here (Fig. 1)
that isocaloric consumption of this diet rich in saturated animal fat (compared with a diet low in fat) results in a more pronounced reduction in energy expenditure in refed animals than in fed controls, thereby revealing an exacerbated suppression of thermogenesis induced by dietary fat during refeeding. Using the same experimental design, we show here that basal and insulin-stimulated IRS1-associated PI3K activity in tibialis anterior is also diminished in response to increased dietary fat, specifically during refeeding. This reduction in PI3K activity in tibialis anterior, a fast-twitch muscle whose fiber composition reflects that observed for the bulk of skeletal mass in the rat (38)
, can also be dissociated in this study from an elevation in circulating FFAs, in intramyocellular lipid content, or in SCD1 up-regulation, all of which are generally associated with obesity-induced insulin resistance and lipotoxicity (39)
. These findings further suggest that suppressed thermogenesis and skeletal muscle insulin sensitivity, both of which require IRS1-associated PI3K activity, are interdependent during catch-up fat.
A role for impaired AMPK signaling in skeletal muscle can also be suggested in the exacerbated suppression of thermogenesis induced by a high-fat diet during refeeding. Our previous studies in intact muscles ex vivo showed that AMPK is required for the direct stimulatory effects of both leptin and corticotropin-releasing hormone on skeletal muscle thermogenesis (28
, 29)
. Furthermore, 5-aminoimidazole-4-carboxamide riboside, a potent AMPK inducer, can also stimulate skeletal muscle thermogenesis (28)
. In this study, we show that AMPK phosphorylation, both basal (unstimulated) and in response to in vivo leptin administration, is lower in both tibialis anterior and soleus muscle of animals refed with a high-fat diet compared with those refed with a low-fat diet. Such impairments in AMPK cannot be consequential to low circulating levels of hormones implicated in the control of AMPK signaling in skeletal muscle—leptin (31)
, thyroid hormone T3 (36)
, and catecholamines (37)
—because plasma concentrations of these hormones are found to be similar or higher during high-fat refeeding than during low-fat refeeding. The observation that AMPK activation in skeletal muscle is decreased in rats refed with a high-fat diet but not with a low-fat diet is consistent with previous reports of defective AMPK signaling in obese and insulin-resistant Zucker rats (40
, 41)
and in rats made obese by feeding with a high-fat diet for several months (42)
. In our study, however, the defective AMPK phosphorylation in response to dietary fat is observed here specifically in refed animals and not in fed controls (Fig. 6)
and before a detectable elevation in circulating FFA and intramyocellular lipid content. These data therefore strongly suggest that the impairment of AMPK activation during high-fat refeeding is an early event that might contribute to the exaggerated suppression of thermogenesis favoring catch-up fat and that refeeding predisposes to the deleterious effects of dietary fat on skeletal muscle AMPK signaling.
Dissociation between muscle SCD1 and thermogenesis
A role for skeletal muscle SCD1 in adaptive thermogenesis was previously proposed on the basis that increased SCD1 gene expression and an increased fatty acid
9 desaturation index (an index for SCD1 activity) correlated with suppressed thermogenesis during refeeding with the standard chow diet (low in fat and high in carbohydrates) (24)
. We show here for the first time that both SCD1 gene expression and the fatty acid
9 desaturation index in skeletal muscle are markedly down-regulated by a high-fat diet, despite the fact that energy expenditure is lower with the high-fat than the low-fat diet in both refed and fed groups (Fig. 1)
. It is possible that such repression of muscle SCD1 by the high-fat diet plays a protective role against lipotoxicity in skeletal muscle, a view that is consistent with our data here showing no significant increase in intramyocellular lipids and also with the observation that SCD1 knockout mice display lower muscle lipid content than wild-type controls (26)
. Nevertheless, our data dissociate skeletal muscle SCD1 activity from the control of whole-body thermogenesis during high-fat consumption. Thus, although knockout of the gene expressing SCD1 results in an hypermetabolic phenotype, and that up-regulation of SCD1 in skeletal muscle correlates with suppressed thermogenesis favoring catch-up fat with a low-fat diet, down-regulation of muscle SCD1 in rats refed (or fed) with a high-fat diet does not increase whole-body thermogenesis. Taken together, these data demonstrate that muscle SCD1 up-regulation per se is not a general requirement for the suppression of thermogenesis that causes catch-up fat.
The main conclusion of the present studies is that IRS1-associated PI3K activity and AMPK activation are defective in skeletal muscle of rat during the early phase of catch-up fat driven by suppressed thermogenesis. Although the exact sequence of events between suppressed thermogenesis and reduced PI3K and AMPK activities remains to be clarified, our view is that suppressed thermogenesis and defective PI3K and AMPK signaling are likely to be interdependent and that these pathways play a major role in the control of skeletal muscle thermogenesis. This hypothesis is consistent with the observations that knockout of the Scd1 gene or at the S6 kinase-1 gene locus in mice leads to resistance to obesity through an elevation in whole-body thermogenesis with enhanced IRS1-associated PI3K activity and AMPK activation in skeletal muscle (22
, 23
, 43
, 44)
.
A molecular mechanism for thrifty metabolism driving catch-up fat
Which molecular effectors of skeletal muscle thermogenesis might be under the control of PI3K and AMPK signaling and which factors contribute to early impairments in these signaling pathways during catch-up fat are questions that need to be addressed in the future. Of particular interest is the recent demonstration that rats showing catch-up fat due to suppressed thermogenesis also show diminished mitochondrial mass and oxidative capacity specifically in the subsarcolemmal compartment of skeletal muscle (45)
. Given the important role that subsarcolemmal mitochondria have for bioenergetic support of signal transduction and substrate transport (46)
, the possibility arises that a deficiency in this subpopulation of mitochondria could contribute to impaired PI3K and AMPK signaling. Although a reduction in the number of subsarcolemmal mitochondria per se is likely to contribute to the suppression of thermogenesis that favors catch-up fat, impaired PI3K and AMPK signaling could also slow down a futile cycle between de novo lipogenesis and mitochondrial lipid oxidation (28
, 29)
.
According to the model presented in Fig. 7
A, PI3K is required for efficient flux of glucose through de novo lipogenesis, and AMPK is required for a sustained flux of de novo synthesized fatty acids through mitochondrial β-oxidation (47)
. This model can be used to explain the mechanisms by which thermogenesis is suppressed in skeletal muscle during catch-up fat. The impact of defective AMPK and PI3K observed during catch-up fat on this futile cycle is illustrated in Fig. 7A, B
for refeeding with a low-fat diet and Fig. 7C, D
for refeeding with the high-fat diet. Thus, during catch-up fat with a low-fat diet (Fig. 7A, B
), the reduction in PI3K will have an impact on several key control points. Being crucial for glucose uptake, impairments in PI3K signaling will indirectly interfere with substrate cycling possibly by decreasing the levels of NADPH, which is required for lipogenesis and by decreasing anaplerosis of the Krebs cycle. Furthermore, PI3K can also exert control over fatty acid synthase (48
, 49)
, and therefore a reduction in PI3K activity might reduce the flux of substrates through de novo lipogenesis leading to a slowdown of the substrate cycle. This model also takes into account our earlier finding that SCD1 is up-regulated in skeletal muscle of rats showing catch-up fat during refeeding with a low-fat (high-carbohydrate) diet (24)
. Such an elevated skeletal muscle SCD1, by desaturating the products of de novo lipogenesis and diverting them away from mitochondrial β-oxidation, could also contribute to decreased substrate cycling between de novo lipogenesis and lipid oxidation; hence, the suppression of thermogenesis that promotes catch-up fat (Fig. 7A, B
). However, during catch-up fat with a high-fat diet (Fig. 7C, D
), SCD1 up-regulation is blunted, but the reductions in IRS1-associated PI3K signaling, together with defective AMPK activation, will inhibit the substrate flux through both lipogenic and β-oxidation pathways that constitute the substrate cycle between de novo lipogenesis and lipid oxidation, thereby explaining the exacerbated suppression of thermogenesis and excess body fat observed during high-fat refeeding.
|
The model presented in Fig. 7
depicts a critical role for diminished muscle PI3K and AMPK signaling in the molecular mechanisms leading to suppressed thermogenesis, which accelerates fat recovery and furthermore sensitizes muscle to dietary fat-induced impairments in PI3K and AMPK signaling. It follows that impairments in these signaling pathways may be part of the molecular mechanisms by which the thrifty metabolism that accelerates fat recovery after caloric restriction confers enhanced susceptibility to obesity and insulin resistance and hence promotes the pathogenesis of metabolic syndrome in individuals who had experienced frequent weight cycling or catch-up growth earlier in life.
| ACKNOWLEDGMENTS |
|---|
Received for publication July 29, 2007. Accepted for publication September 13, 2007.
| REFERENCES |
|---|
|
|
|---|
(PI3K
): functions of lipid kinase-deficient PI3K
in signalling. J. Biol. Chem. 276,21544-21554
1-adrenoceptors causing glucose uptake. Diabetes 55,682-690This article has been cited by other articles:
![]() |
K. J. Berleze, A. P. Muller, I. D. Schweigert, A. Longoni, F. Sordi, A. M. de Assis, L. N. Rotta, D. O. G. de Souza, and M. L. S. Perry Gestational and Postnatal Low Protein Diet Alters Insulin Sensitivity in Female Rats Exp Biol Med, December 1, 2009; 234(12): 1437 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Summermatter, H. Marcelino, D. Arsenijevic, A. Buchala, O. Aprikian, F. Assimacopoulos-Jeannet, J. Seydoux, J.-P. Montani, G. Solinas, and A. G. Dulloo Adipose Tissue Plasticity During Catch-Up Fat Driven by Thrifty Metabolism: Relevance for Muscle-Adipose Glucose Redistribution During Catch-Up Growth Diabetes, October 1, 2009; 58(10): 2228 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. MacLean, J. A. Higgins, H. R. Wyatt, E. L. Melanson, G. C. Johnson, M. R. Jackman, E. D. Giles, I. E. Brown, and J. O. Hill Regular exercise attenuates the metabolic drive to regain weight after long-term weight loss Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Dulloo Adipose Tissue Plasticity in Catch-Up-Growth Trajectories to Metabolic Syndrome: Hyperplastic Versus Hypertrophic Catch-Up Fat Diabetes, May 1, 2009; 58(5): 1037 - 1039. [Full Text] [PDF] |
||||
![]() |
M. R. Jackman, A. Steig, J. A. Higgins, G. C. Johnson, B. K. Fleming-Elder, D. H. Bessesen, and P. S. MacLean Weight regain after sustained weight reduction is accompanied by suppressed oxidation of dietary fat and adipocyte hyperplasia Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1117 - R1129. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |